Researchers study link between insulin use and cancer in people with diabetes
December 23, 2009 Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine, a synthetic insulin preparation marketed under the trade name Lantus, may be associated with a higher risk of certain cancers than other insulins or oral glucose-lowering medications. However, these studies were... Read more »